A study published this month in Arthritis and Rheumatology concluded that nonsteroidal anti-inflammatory drugs (NSAID) may elevate the cardiovascular risk for patients with osteoarthritis. “Patients with OA were nearly 25% more likely than patients without OA to develop CVD (adjusted hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.17 – 1.28). The researchers estimate that 41% of the increased CVD risk in those with OA was related to NSAID use,” according to a report by Medscape. Full story.
Categories
- AAHKS Amplified (21)
- AAHKS Business (120)
- AAHKS Leadership (68)
- Advocacy (169)
- AJRR (48)
- Annual Meeting (223)
- Arthroplasty Topics Podcast (40)
- Bundled Payments (12)
- Certification (1)
- CME (15)
- CMS (151)
- Co-Branded Meetings (15)
- Committees and Task Forces (31)
- Corporate Partners (25)
- COVID-19 (37)
- Digital Health (4)
- Digital Health Podcast (2)
- Diversity (7)
- Education (80)
- eMentor (4)
- Federal Guidelines (39)
- Fellowships (35)
- FOCAL (13)
- Foundation (15)
- Guidelines (8)
- Humanitarian Award (7)
- Humanitarian Organizations (17)
- In Memoriam (15)
- In the News (241)
- Industry (17)
- International (37)
- Legislation (60)
- Medicare (93)
- Membership (42)
- New Orthopaedic Headquarters (5)
- News Releases (10)
- Operation Walk (6)
- Opioids (7)
- Patient Education (50)
- Patient Outcomes (14)
- Performance Measures (17)
- Popular (56)
- Position Papers (8)
- Practice Management (26)
- Promotions (15)
- Publications (95)
- Research (196)
- Residents (36)
- Social Media (7)
- Specialty Day (7)
- Spring Meeting (47)
- Surveys (17)
- Technology (13)
- The Match (14)
- Uncategorized (25)
- Video (6)
- Webinars (49)
- Website (11)
- Women in Arthroplasty (9)
- Women in Arthroplasty Podcast (1)
- Young Arthroplasty Group (4)
- Young Arthroplasty Group Podcast (2)